Alyeska Investment Group, L.P. - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 83 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2019. The put-call ratio across all filers is 0.87 and the average weighting 1.1%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q4 2020$2,083,000
+5.3%
536,847
+9.3%
0.03%
-3.3%
Q3 2020$1,979,000
+32.2%
491,141
+39.8%
0.03%
+30.4%
Q2 2020$1,497,000
-40.8%
351,425
-45.4%
0.02%
-30.3%
Q4 2019$2,529,000
+24.5%
643,444
+103.7%
0.03%
+22.2%
Q1 2019$2,031,000
-19.3%
315,910
+152.7%
0.03%
-3.6%
Q3 2018$2,516,000
+72.4%
125,000
+150.0%
0.03%
+115.4%
Q2 2018$1,459,000
+132.3%
50,000
+137.2%
0.01%
+160.0%
Q1 2018$628,000
-73.8%
21,075
-73.8%
0.01%
-75.0%
Q2 2017$2,399,000
+7.1%
80,583
+7.4%
0.02%
+11.1%
Q1 2017$2,239,00075,0000.02%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2019
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,018,00094.79%
TANG CAPITAL MANAGEMENT LLC 9,405,490$39,879,00011.22%
RTW INVESTMENTS, LP 2,327,903$9,870,0000.15%
Boxer Capital, LLC 890,700$3,777,0000.13%
FIRST MIDWEST BANK TRUST DIVISION 89,341$379,0000.05%
WealthTrust Axiom LLC 30,400$128,0000.04%
PREMIER ASSET MANAGEMENT LLC 51,305$217,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 18,113$77,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 39,000$165,0000.02%
Inscription Capital, LLC 10,000$42,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders